China Resources Sanjiu Medical & Pharmaceutical Co., Ltd. (SHE:000999)

Market Cap	40.14B -18.2%
Revenue (ttm)	31.81B +12.3%
Net Income	3.28B +17.7%
EPS	1.97 +17.9%
Shares Out	1.66B
PE Ratio	12.24
Forward PE	10.27
Dividend	1.04 (4.31%)
Ex-Dividend Date	May 29, 2026

Volume	6,807,125
Open	24.25
Previous Close	24.12
Day's Range	23.68 - 24.25
52-Week Range	21.60 - 30.65
Beta	-0.02
Analysts	Buy
Price Target	35.15 (+47.44%)
Earnings Date	Aug 22, 2026

About SHE:000999

China Resources Sanjiu Medical & Pharmaceutical Co., Ltd. engages in the research and development, production, and sale of pharmaceutical products in the People’s Republic of China and internationally. The company offers health consumer products (CHC), including cold, flu, skin, gastrointestinal, cough, orthopedics, pediatrics drugs, and dietary nutritional supplements; and prescription drug products, such as anti-tumor, cardiovascular and cerebrovascular, digestive system, orthopedics, pediatrics, anti-infection, and other treatment areas; Chi...

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 1999
• Employees: 30,304
• Stock Exchange: Shenzhen Stock Exchange
• Ticker Symbol: 000999

Financial Performance

In 2025, SHE:000999's revenue was 31.60 billion, an increase of 14.43% compared to the previous year's 27.62 billion. Earnings were 3.42 billion, an increase of 1.58%.

Analyst Summary

According to 11 analysts, the average rating for 000999 stock is "Buy." The 12-month stock price target is ¥35.15, which is an increase of 47.44% from the latest price.

Price Target

¥35.15

(47.44% upside)

Analyst Consensus: Buy

Data Sources: S&P Global Market Intelligence and Financial Modeling Prep

Fundamental and historical data is provided by S&P Global Market Intelligence. Delayed stock pricing data is provided by Financial Modeling Prep.

Last checked:

Sep 16, 2026

Data Sources Report a data error